Literature DB >> 11523568

Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents.

S Kösel1, E M Grasbon-Frodl, K Arima, L Chimelli, M Hahn, Y Hashizume, C Hulette, K Ikeda, P F Jacobsen, M Jones, M Kobayashi, S Love, T Mizutani, S Rosemberg, A Sasaki, T W Smith, H Takahashi, A O Vortmeyer, M B Graeber.   

Abstract

DNA extracted from formalin-fixed and paraffin-embedded brain tissue is known to contain as yet ill-characterized inhibitors of the PCR process. As part of a project that aims to clarify the role of mitochondrial DNA sequence variation in human neurodegenerative diseases using DNA from various ethnic backgrounds, we have investigated factors that influence the preservation of archival DNA and its suitability for PCR. In this study, neuropathological tissue samples were analysed that had been routinely processed in 18 international centres on four continents. Following DNA extraction, PCR amplification of mitochondrial and nuclear DNA sequences was performed with and without additional purification of the template DNA. In addition, the DNA used for PCR was analysed by HPLC. Phosphate-buffered formalin proved to be a superior fixative compared with unbuffered aldehyde: DNA extraction resulted in greater yields, the molecular weight of the isolated DNA was higher and PCR was more successful. PCR inhibitors were identified as (1) high concentrations of small (<300 bp) DNA fragments that competitively compete with template DNA and (2) contaminants of the DNA template solution including denatured protein that cannot be completely removed by phenolic extraction. HPLC analysis did not reveal significant qualitative differences between DNA isolated from fresh-frozen tissue samples and DNA recovered from formalin-fixed, paraffin-embedded brain tissue. The fact that DNA could be amplified from the majority of tissue specimens in this study suggests that rare diseases and diseases where ethnic background plays an important role can be sampled for genetic polymorphism analysis on a global scale using archival neuropathological collections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523568     DOI: 10.1007/s100480100114

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  6 in total

1.  Limited tissue fixation times and whole genomic amplification do not impact array CGH profiles.

Authors:  A A Ghazani; N C R Arneson; K Warren; S J Done
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

2.  DNA and RNA analysis of blood and muscle from bodies with variable postmortem intervals.

Authors:  Jakob Hansen; Iana Lesnikova; Anette Mariane Daa Funder; Jytte Banner
Journal:  Forensic Sci Med Pathol       Date:  2014-06-10       Impact factor: 2.007

3.  Genotypes of JC virus, DNA of cytomegalovirus, and proviral DNA of human immunodeficiency virus in eyes of acquired immunodeficiency syndrome patients.

Authors:  Philipp Eberwein; Lutz L Hansen; Hansjürgen T Agostini
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

4.  Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.

Authors:  Vassiliki Kotoula; Elpida Charalambous; Bart Biesmans; Andigoni Malousi; Eleni Vrettou; George Fountzilas; George Karkavelas
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

5.  Molecular cytogenetic characterization of tenosynovial giant cell tumors.

Authors:  Petter Brandal; Bodil Bjerkehagen; Sverre Heim
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

6.  Epstein-Barr virus as a marker of biological aggressiveness in breast cancer.

Authors:  C Mazouni; F Fina; S Romain; L Ouafik; P Bonnier; J-M Brandone; P-M Martin
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.